RxDoctor Payments Data

Jon Miller, DO

General Practice · Logan, WVNPI 1841245339

Payments from drug & device makers

$987in general payments, 2019–2025

Across 61 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$262
  • Pfizer$210
  • Amarin Pharma, Inc.$112
  • Boehringer Ingelheim$80
  • Amgen$55
  • AbbVie$46
  • plus $221 from 9 others

What the payments were for

  • Food & beverage$987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$987 in reported general payments places this provider in the 80th percentile of 437 general practice providers in West Virginia.

See all general practice providers in West Virginia

Medicare billing

Part B allowed, 2024
$87,098
Medicare patients
121
Services billed
1,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$54,008
RybelsusSemaglutide21$40,578
EliquisApixaban35$29,982
Tresiba Flextouch U-200Insulin Degludec29$29,460
XareltoRivaroxaban24$27,271
JanuviaSitagliptin Phosphate15$22,561
JardianceEmpagliflozin21$22,047
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$18,377
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen499$11,018
VascepaIcosapent Ethyl11$6,302
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$3,727
SynthroidLevothyroxine Sodium54$3,271
Icosapent Ethyl11$2,614
Levothyroxine Sodium330$2,438
Levemir FlexpenInsulin Detemir13$2,067

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$262$94,58660 claims
PfizerEliquis$210$29,98235 claims
Boehringer IngelheimJardiance$80$22,04721 claims
AbbVieSynthroid$46$3,27154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 437 general practice providers in West Virginia.

Other general practice in Logan

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →